Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bydureon Goes Back To The QTc Drawing Board

Related Content

Amylin Hit Hardest By Bydureon Setback

Oct 20 2010

FDA's "Complete Response" Letter For Byetta LAR Isn't Too Onerous, Amylin Says

Mar 15 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window